chlorpromazine has been researched along with u 73122 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Raucher, D; Sheetz, MP | 1 |
| Basta-Kaim, A; Budziszewska, B; Jaworska-Feil, L; Kubera, M; Lasoń, W; Leśkiewicz, M; Tetich, M | 1 |
| Collins, KM; Fratti, RA; Hickey, CM; Wickner, W | 1 |
3 other study(ies) available for chlorpromazine and u 73122
| Article | Year |
|---|---|
Phospholipase C activation by anesthetics decreases membrane-cytoskeleton adhesion.
Topics: 3T3 Cells; Anesthetics, Local; Animals; Antipsychotic Agents; Calcium; Cell Membrane; Cell Membrane Permeability; Chlorpromazine; Cytoskeleton; Enzyme Activation; Estrenes; Green Fluorescent Proteins; Lasers; Lidocaine; Luminescent Proteins; Mice; Micromanipulation; Microscopy, Confocal; Molecular Structure; Phosphatidylinositol 4,5-Diphosphate; Phospholipids; Pyrrolidinones; Recombinant Fusion Proteins; Type C Phospholipases | 2001 |
Chlorpromazine inhibits the glucocorticoid receptor-mediated gene transcription in a calcium-dependent manner.
Topics: Animals; Antipsychotic Agents; Calcimycin; Calcium; Calcium Channel Blockers; Cell Line; Cell Line, Transformed; Chloramphenicol O-Acetyltransferase; Chlorpromazine; Clozapine; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Estrenes; Fibroblasts; Gene Expression Regulation; Genes, Reporter; Haloperidol; Histamine; Histamine H1 Antagonists; Ionophores; Mammary Tumor Virus, Mouse; Mice; Nifedipine; Phorbol Esters; Phosphodiesterase Inhibitors; Protein Kinase C; Protein Kinase C-alpha; Pyrilamine; Pyrrolidinones; Raclopride; Receptors, Glucocorticoid; Remoxipride; Sulfonamides; Sulpiride; Tetradecanoylphorbol Acetate; Thionucleotides; Transcription, Genetic; Type C Phospholipases | 2002 |
Stringent 3Q.1R composition of the SNARE 0-layer can be bypassed for fusion by compensatory SNARE mutation or by lipid bilayer modification.
Topics: Chlorpromazine; Dopamine Antagonists; Estrenes; Lipid Bilayers; Membrane Fusion; Multiprotein Complexes; Mutation; Phosphodiesterase Inhibitors; Pyrrolidinones; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; SNARE Proteins; Type C Phospholipases; Vacuoles | 2007 |